New drug aims to lower dangerous blood fats in High-Risk patients
Disease control
Recruiting now
This study tests an experimental drug called RBD5044 in 120 adults with mixed dyslipidemia, a condition where blood fat levels are too high. Participants will receive either the drug or a placebo twice over 12 months to see if it safely lowers triglycerides. The goal is to contro…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC